Rallybio Stock Quote RLYB - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.10

Bid

1.10

Ask

1.23

Volume

65,121

1.10 Day's Range 1.13

1.08 52 Week Range 5.03

Market Cap

45.636M

Previous Close

1.10

Open

1.13

Last Trade

1952

1.1

(formt)

Last Trade Time

Financial Volume

$ 72,278

VWAP

1.1099

Average Volume (3m)

100,120

Shares Outstanding

41,487,586

Dividend Yield

PE Ratio

-0.62

Earnings Per Share (EPS)

-1.8

Revenue

Net Profit

-74.56M

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.rallybio.com.

Headquarters

Wilmington, Delaware, USA

Founded

Rallybio Holdings LLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was $1.10. Over the last year, Rallybio shares have traded in a share price range of $ 1.08 to $ 5.03.

Rallybio currently has 41,487,586 shares outstanding. The market capitalization of Rallybio is $45.64 million. Rallybio has a price to earnings ratio (PE ratio) of -0.62.

FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

Form 8-K - Current report

Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, announced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.01	-0.900900900901	1.11	1.1907	1.09	40414	1.10833148	CS
4	-0.02	-1.78571428571	1.12	1.25	1.08	64259	1.13371076	CS
12	-0.39	-26.1744966443	1.49	1.54	1.08	100120	1.25534532	CS
26	-0.52	-32.0987654321	1.62	3.46	1.08	844751	2.65632429	CS
52	-3.85	-77.7777777778	4.95	5.03	1.08	504276	2.57374342	CS
156	-11.75	-91.439688716	12.85	21	1.08	222526	4.11258216	CS
260	-13.82	-92.6273458445	14.92	25.78	1.08	221248	4.56477349	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OMEXOdyssey Marine Exploration Inc	$ 1.39 (180.07%)	328.97M
PRTGPortage Biotech Inc	$ 9.7581 (115.41%)	51.55M
APLTApplied Therapeutics Inc	$ 7.86 (69.03%)	51.67M
XCHXCHG Ltd	$ 18.40 (65.77%)	1.26M
WBUYWeBuy Global Ltd	$ 0.1867 (60.95%)	248.03M
GLMDGalmed Pharmaceuticals Ltd	$ 6.83 (-54.77%)	6.24M
KAKineta Inc	$ 0.5691 (-31.35%)	530.74k
DTSSDatasea Inc	$ 2.07 (-29.59%)	1.34M
CBUSCibus Inc	$ 3.595 (-28.95%)	2.31M
BFIBurgerFi International Inc	$ 0.1705 (-26.98%)	16.56M
OMEXOdyssey Marine Exploration Inc	$ 1.39 (180.07%)	328.97M
NVDANVIDIA Corporation	$ 113.37 (-1.92%)	310.35M
WBUYWeBuy Global Ltd	$ 0.1867 (60.95%)	248.03M
SQQQProShares UltraPro Short QQQ	$ 8.40 (1.45%)	200.73M
LUNRIntuitive Machines Inc	$ 7.4512 (37.99%)	141.86M